Effect of autologous platelet-rich plasma combined physiotherapy on thin endometrial growth and pregnancy outcome during the frozen embryo transfer cycle

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026875

Enrollment

Unknown

Registered

2019-10-24

Start date

2019-10-15

Completion date

Unknown

Last updated

2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thin endometrium

Interventions

Experimental group:autologous platelet-rich plasma combined physiotherapy

control group:HRT

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients receiving FET and meting the following inclusion criteria: (1) aged 20 to 40 years old; (2) with cancellation history of embryo transfer due to thin endometrium (<7mm) in hormone replacement therapy(HRT) cycles; (3) transfer one blastocyst or two blastomeres, at least one of which is good-quality.

Exclusion criteria

Exclusion criteria: Patients with any other known cause of implantation failure, such as poor embryo quality, congenital or acquired uterine abnormalities, or Asherman syndrome.

Design outcomes

Primary

Measure	Time frame
endometrial thickness;pregnancy outcomes;	—

Countries

China

Contacts

Public ContactYingchun Zhang

Ji'nan Central Hospital Affiliated to Shandong University

chunerbaby@sina.com+86 0531-85695777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026